Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Vasorelaxant potencies and receptor binding affinities of atrial natriuretic hormone (ANH) analogues

Conference · · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
OSTI ID:5324428
ANH (1-28) (..cap alpha..-rat ANP) produces hypotensive effects in vivo, presumably via interaction with specific receptors. Vasorelaxant potencies (pD/sub 2/) and intrinsic activities of ANH analogues were measured in histamine constricted rabbit aorta rings. Binding affinities (K/sub I/) of the compounds were studied in rabbit aorta renal cortex and adrenal, using the radio-ligand /sup 125/I-Tyr/sup 28/-ANH (1-28). Significant correlations (r < -.90; p < .01) between the pD/sub 2/s in aorta, and the log D/sub I/s in each of the three tissues were observed for the following cyclic compounds, listed in order of potency: ANH (1-28) greater than or equal to ANH (6-28) greater than or equal to Met/sup 12/-ANH (1-28) (..cap alpha..-human ANP) greater than or equal to cyclohexyl-Ala (Cha)/sup 8/-ANH (5-28) > Lys/sup 11/-ANH (5-28) = ANH (5-28) (atriopeptin III) = ANH (5-27) (atriopeptin II) = Cha/sup 21/-ANH (5-28) greater than or equal to ANH (7-28) > Cha/sup 15/-ANH (5-28) = Pro/sup 10/-ANH (5-28) = ANH (5-25) (atriopeptin I) = Asn/sup 13/-ANH (5-28) = Tyr/sup 9/-ANH (5-28) > des-Gly/sup 9/-ANH (5-28) > ANH (7-23) = Pro/sup 10/-ANH (7-23) greater than or equal to (D)Ala/sup 9/-ANH (7-23) > Pro/sup 9/-ANH (7-13). In summary, the affinities of several ANH analogues for both vascular and nonvascular receptors agree with their vasorelaxant potencies.
Research Organization:
Abbott Labs., Abbott Park, IL
OSTI ID:
5324428
Report Number(s):
CONF-8604222-
Conference Information:
Journal Name: Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) Journal Volume: 45:3
Country of Publication:
United States
Language:
English